Stay updated on Phase I Dose Escalation Clinical Trial S64315 with Venetoclax

Sign up to get notified when there's something new on the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page.
Latest website image capture
Clouds background image

Latest updates to the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page

  1. Check
    today
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-21T21:42:33.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page, indicating a minor version update with no changes to study data or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T09:22:44.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1 on the Record History page.
    Difference
    0.1%
    Check dated 2025-11-23T07:51:16.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page history shows the deletion of a government operating-status notice from the record page; core trial data and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-16T05:52:12.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The new screenshot shows an additional version entry in the Study Record Versions list; the page layout and core identifiers remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-01T23:59:49.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    - Introduces a prominent operating-status notice and a version upgrade to v3.2.0; indicates potential delays in processing and inquiries due to funding gaps and points users to official status sources. - Removes the previous v3.1.0 reference, now presenting v3.2.0.
    Difference
    11%
    Check dated 2025-10-04T03:08:32.000Z thumbnail image

Stay in the know with updates to Phase I Dose Escalation Clinical Trial S64315 with Venetoclax

Enter your email address, and we'll notify you when there's something new on the Phase I Dose Escalation Clinical Trial S64315 with Venetoclax page.